Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-03-23 15:45:33 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://jamanetwork.com/journals/jama/fullarticle/2828232
其他信息:
出版社: American Medical Association (AMA)
作者: Li Chen; Hui Li; Hao Zhang; Huawei Yang; Jun Qian; Zhihua Li; Yu Ren; Shu Wang; Peifen Fu; Hongjian Yang; Yunjiang Liu; Jing Sun; Jianyun Nie; Ruiwen Lei; Yongzhong Yao; Anqin Zhang; Shouman Wang; Xiaopeng Ma; Zhong Ouyang; Hongwei Yang; Song-Yang Wu; Shuo-Wen Cao; Kun Wang; Aimei Jiang; Quchang Ouyang; Da Pang; Limin Wei; Xiaoming Zha; Yu Shen; Xiangwen Qu; Fei Wu; Xiaoyu Zhu; Zhonghua Wang; Lei Fan; Zhi-Ming Shao

